85% of lung cancers are diagnosed late stage | EarlyCDT-Lung

85% of lung cancers are diagnosed late stage

Find lung cancer before symptoms appear. EarlyCDT-Lung combined with CT can help.

Learn More
Autoantibodies are detectible up to 5 years before a tumor is visible.

EarlyCDT-Lung:

Panel of autoantibodies to aid in early lung cancer detection

Learn More

When Found Early Stage, 5 Year Survival Rate More Than Triples

Recent NLST Trial further shows 20% mortality improvement. EarlyCDT-Lung can reduce false positives associated with CT.

Learn More

EarlyCDT-Lung is a simple blood test that:

  • Has nearly 4 times better Positive Predictive Value (PPV) than CT
  • Has 7 times fewer false positives than CT
  • Detects all types and all stages of lung cancer, including at the earliest stages
  • Is reimbursed by Medicare Part B and private insurance
  • Positive test implies 3-5x risk of cancer
Learn More

Primary Care Physicians

Your Challenge with Lung Cancer

How to identify the relatively small percentage of lung cancers (5-50 depending on the level of risk), per 1,000, that are present in your high-risk patient population. More….

 

USE OF EarlyCDT-Lung:

  • As a risk assessment test to aid in the early detection of lung cancer in your high-risk patients; most notably long-term smokers and ex-smokers.
  • A new tool to risk stratify pulmonary nodules. More…

Pulmonologists

Your Challenge with Lung Cancer

Risk stratify patients with pulmonary nodules and other at risk patient populations (ie COPD patients); How to identify the relatively small percentage of lung cancers that are present in your high-risk patient population with pulmonary nodules. More…

USE OF EarlyCDT-Lung:
  • Risk stratify pulmonary nodules especially those where PET is less conclusive.
  • To aid in the early detection of lung cancer in your high-risk patients; most notably long-term smokers and ex-smokers (ie COPD patients). More…
Keep up with EarlyCDT...
Your email: